Predicting events in clinical trials using two time-to-event outcomes

被引:0
|
作者
Mu, Rongji [1 ,2 ]
Xu, Jin [1 ]
机构
[1] East China Normal Univ, Sch Stat, Shanghai 200241, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
基金
中国国家自然科学基金;
关键词
change point; convolution; event prediction; overall survival; progression-free survival; PROGRESSION-FREE SURVIVAL; SURROGATE; HAZARD; MODEL; ASSOCIATION; DEPENDENCE;
D O I
10.1002/bimj.201700083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In clinical trials with time-to-event outcomes, it is of interest to predict when a prespecified number of events can be reached. Interim analysis is conducted to estimate the underlying survival function. When another correlated time-to-event endpoint is available, both outcome variables can be used to improve estimation efficiency. In this paper, we propose to use the convolution of two time-to-event variables to estimate the survival function of interest. Propositions and examples are provided based on exponential models that accommodate possible change points. We further propose a new estimation equation about the expected time that exploits the relationship of two endpoints. Simulations and the analysis of real data show that the proposed methods with bivariate information yield significant improvement in prediction over that of the univariate method.
引用
收藏
页码:815 / 826
页数:12
相关论文
共 50 条
  • [31] A multistate platform model for time-to-event endpoints in oncology clinical trials
    Lin, Chih-Wei
    Nagase, Mario
    Doshi, Sameer
    Dutta, Sandeep
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (01): : 154 - 167
  • [32] Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints
    Beisel, Christina
    Benner, Axel
    Kunz, Christina
    Kopp-Schneider, Annette
    BIOMETRICAL JOURNAL, 2017, 59 (03) : 511 - 530
  • [33] Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome
    Munda, Marco
    Legrand, Catherine
    PHARMACEUTICAL STATISTICS, 2014, 13 (02) : 145 - 152
  • [34] Sample sizes for clinical trials with time-to-event endpoints and competing risks
    Schulgen, G
    Olschewski, M
    Krane, V
    Wanner, C
    Ruf, G
    Schumacher, M
    CONTEMPORARY CLINICAL TRIALS, 2005, 26 (03) : 386 - 396
  • [35] Editor's Note: Special Section on Estimands, Design and Analysis of Clinical Trials with Time-to-Event Outcomes
    Hamasaki, Toshimitsu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (02): : 237 - 237
  • [36] Meta-analysis of clinical trials with competing time-to-event endpoints
    Meddis, Alessandra
    Latouche, Aurelien
    Zhou, Bingqing
    Michiels, Stefan
    Fine, Jason
    BIOMETRICAL JOURNAL, 2020, 62 (03) : 712 - 723
  • [37] Analysis of Time-to-Event Data Under a Two-Stage Survival Adaptive Design in Clinical Trials
    Lu, Qingshu
    Tse, Siu Keung
    Chow, Shein-Chung
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (04) : 705 - 719
  • [38] Transportability Methods for Time-to-Event Outcomes: Application in Adjuvant Colon Cancer Trials
    Zuo, Shuozhi
    Josey, Kevin P.
    Raghavan, Sridharan
    Yang, Fan
    Juarez-Colunga, Elizabeth
    Ghosh, Debashis
    JCO CLINICAL CANCER INFORMATICS, 2022, 6 : e2200088
  • [39] RARtool: A MATLAB Software Package for Designing Response-Adaptive Randomized Clinical Trials with Time-to-Event Outcomes
    Ryeznik, Yevgen
    Sverdlov, Oleksandr
    Wong, Weng Kee
    JOURNAL OF STATISTICAL SOFTWARE, 2015, 66 (01):
  • [40] Confirmatory Adaptive Designs for Clinical Trials With Multiple Time-to-Event Outcomes in Multi-state Markov Models
    Danzer, Moritz Fabian
    Faldum, Andreas
    Simon, Thorsten
    Hero, Barbara
    Schmidt, Rene
    Biometrical Journal, 66 (07):